Side event during the Fourth International Conference on Financing for DevelopmentAccess to essential health products is a fundamental aspect of global health equity. The COVID-19 pandemic exposed critical vulnerabilities in global supply chains, particularly in access to essential health products. Many low- and middle-income countries (LMICs) worldwide experienced severe disruptions in the availability of diagnostics, therapeutics, and vaccines due to over-reliance on external suppliers and a lack of regional manufacturing capacity.Read More
